Assessment of Cognitive Function in Systemic Lupus Erythematosus

Kimberley Yuen; Mahta Kakvan; Oshrat E. Tayer-Shifman; Nathalie Rozenbojm; Kathleen Bingham; Zahi Touma

doi:10.1007/978-3-030-73303-2_13

Assessment of Cognitive Function in Systemic Lupus Erythematosus

Kimberley Yuen, Mahta Kakvan, Oshrat E. Tayer-Shifman, Nathalie Rozenbojm, Kathleen Bingham, Zahi Touma^*

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Cognitive impairment (CI) is common in patients with systemic lupus erythematosus (SLE), with a pooled prevalence of 38% (95% confidence interval: 33–43%). While common, screening and diagnosing CI can be challenging. Cognitive impairment is often associated with physiological and psychological factors that can greatly impact the quality of life of patients with SLE. This chapter covers several topics under the umbrella of cognitive functioning in patients with SLE, including an overview of the definition and prevalence of CI in patients with SLE, instruments for measuring cognitive function, the ongoing heterogeneity of CI definition and assessment in patients with SLE, changes in cognition over time, the association between cognition and other comorbidities such as depression and anxiety, the relationship between cognition and patient health-related quality of life, and the association between cytokines and antibodies in relation to cognition.

Original language	English
Title of host publication	Outcome Measures and Metrics in Systemic Lupus Erythematosus
Publisher	Springer International Publishing
Pages	251-285
Number of pages	35
ISBN (Electronic)	9783030733032
ISBN (Print)	9783030733025
DOIs	https://doi.org/10.1007/978-3-030-73303-2_13
State	Published - 1 Jan 2021
Externally published	Yes

Keywords

Antibodies
Anxiety
Cognitive impairment
Cytokines
Depression
Health-related quality of life
Neuropsychological measurement
Systemic lupus erythematosus

Access to Document

10.1007/978-3-030-73303-2_13

Cite this

@inbook{a51abfd6810d47499c3a347655f8bbdf,

title = "Assessment of Cognitive Function in Systemic Lupus Erythematosus",

abstract = "Cognitive impairment (CI) is common in patients with systemic lupus erythematosus (SLE), with a pooled prevalence of 38% (95% confidence interval: 33–43%). While common, screening and diagnosing CI can be challenging. Cognitive impairment is often associated with physiological and psychological factors that can greatly impact the quality of life of patients with SLE. This chapter covers several topics under the umbrella of cognitive functioning in patients with SLE, including an overview of the definition and prevalence of CI in patients with SLE, instruments for measuring cognitive function, the ongoing heterogeneity of CI definition and assessment in patients with SLE, changes in cognition over time, the association between cognition and other comorbidities such as depression and anxiety, the relationship between cognition and patient health-related quality of life, and the association between cytokines and antibodies in relation to cognition.",

keywords = "Antibodies, Anxiety, Cognitive impairment, Cytokines, Depression, Health-related quality of life, Neuropsychological measurement, Systemic lupus erythematosus",

author = "Kimberley Yuen and Mahta Kakvan and Tayer-Shifman, {Oshrat E.} and Nathalie Rozenbojm and Kathleen Bingham and Zahi Touma",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2021, corrected publication 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-3-030-73303-2_13",

language = "אנגלית",

isbn = "9783030733025",

pages = "251--285",

booktitle = "Outcome Measures and Metrics in Systemic Lupus Erythematosus",

publisher = "Springer International Publishing",

address = "שוויץ",

}

TY - CHAP

T1 - Assessment of Cognitive Function in Systemic Lupus Erythematosus

AU - Yuen, Kimberley

AU - Kakvan, Mahta

AU - Tayer-Shifman, Oshrat E.

AU - Rozenbojm, Nathalie

AU - Bingham, Kathleen

AU - Touma, Zahi

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021, corrected publication 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Cognitive impairment (CI) is common in patients with systemic lupus erythematosus (SLE), with a pooled prevalence of 38% (95% confidence interval: 33–43%). While common, screening and diagnosing CI can be challenging. Cognitive impairment is often associated with physiological and psychological factors that can greatly impact the quality of life of patients with SLE. This chapter covers several topics under the umbrella of cognitive functioning in patients with SLE, including an overview of the definition and prevalence of CI in patients with SLE, instruments for measuring cognitive function, the ongoing heterogeneity of CI definition and assessment in patients with SLE, changes in cognition over time, the association between cognition and other comorbidities such as depression and anxiety, the relationship between cognition and patient health-related quality of life, and the association between cytokines and antibodies in relation to cognition.

AB - Cognitive impairment (CI) is common in patients with systemic lupus erythematosus (SLE), with a pooled prevalence of 38% (95% confidence interval: 33–43%). While common, screening and diagnosing CI can be challenging. Cognitive impairment is often associated with physiological and psychological factors that can greatly impact the quality of life of patients with SLE. This chapter covers several topics under the umbrella of cognitive functioning in patients with SLE, including an overview of the definition and prevalence of CI in patients with SLE, instruments for measuring cognitive function, the ongoing heterogeneity of CI definition and assessment in patients with SLE, changes in cognition over time, the association between cognition and other comorbidities such as depression and anxiety, the relationship between cognition and patient health-related quality of life, and the association between cytokines and antibodies in relation to cognition.

KW - Antibodies

KW - Anxiety

KW - Cognitive impairment

KW - Cytokines

KW - Depression

KW - Health-related quality of life

KW - Neuropsychological measurement

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85160483995&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-73303-2_13

DO - 10.1007/978-3-030-73303-2_13

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:85160483995

SN - 9783030733025

SP - 251

EP - 285

BT - Outcome Measures and Metrics in Systemic Lupus Erythematosus

PB - Springer International Publishing

ER -

Assessment of Cognitive Function in Systemic Lupus Erythematosus

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this